Paul-Louis Woerther

Paul-Louis Woerther

Auto-generated profile, based on publicly available information

Paul-Louis Woerther

Unité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor , AP-HP, Créteil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
PWPaul-Louis Woerther
Paul-Louis Woerther
RLRaphaël Lepeule
Raphaël Lepeule
CBCharles Burdet
Charles Burdet
JDJean-Winoc Decousser
Jean-Winoc Decousser
ÉRÉtienne Ruppé
Étienne Ruppé
FBFrançois Barbier
François Barbier

6 April 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
CLClaudie Lamoureux
Claudie Lamoureux
LSLaure Surgers
Laure Surgers
VFVincent Fihman
Vincent Fihman
GGGuillaume Gricourt
Guillaume Gricourt
VDVanessa Demontant
Vanessa Demontant
PWPaul-Louis Woerther
Paul-Louis Woerther
Bacteriological diagnosis is traditionally based on culture. However, this method may be limited by the difficulty of cultivating certain species or by prior exposure to antibiotics, which justifies the resort to molecular methods, such as Sanger sequencing of the 16S rRNA gene (Sanger 16S). Recently, shotgun metagenomics (SMg) has emerged as a powerful tool to identify a wide range of pathogenic microorganisms in numerous clinical contexts. In this study, we compared the performance of SMg to Sanger 16S for bacterial detection and identification. All patients’ samples for which Sanger 16S was requested between November 2019 and April 2020 in our institution were prospectively included. The corresponding samples were tested with a commercial 16S semi-automated method and a semi-quantitative pan-microorganism DNA- and RNA-based SMg method. Sixty-seven samples from 64 patients were analyzed. Overall, SMg was able to identify a bacterial etiology in 46.3% of cases (31/67) vs. 38.8% (26/67) with Sanger 16S. This difference reached significance when only the results obtained at the species level were compared (28/67 vs. 13/67). This study provides one of the first evidence of a significantly better performance of SMg than Sanger 16S for bacterial detection at the species level in patients with infectious diseases for whom culture-based methods have failed. This technology has the potential to replace Sanger 16S in routine practice for infectious disease diagnosis.

13 September 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
TUTomas Urbina
Tomas Urbina
KRKeyvan Razazi
Keyvan Razazi
COClément Ourghanlian
Clément Ourghanlian
PWPaul-Louis Woerther
Paul-Louis Woerther
OCOlivier Chosidow
Olivier Chosidow
NPNicolas de Prost
Nicolas de Prost
Necrotizing soft tissue infections (NSTIs) are rare life-threatening bacterial infections characterized by an extensive necrosis of skin and subcutaneous tissues. Initial urgent management of NSTIs relies on broad-spectrum antibiotic therapy, rapid surgical debridement of all infected tissues and, when present, treatment of associated organ failures in the intensive care unit. Antibiotic therapy for NSTI patients faces several challenges and should (1) carry broad-spectrum activity against gram-positive and gram-negative pathogens because of frequent polymicrobial infections, considering extended coverage for multidrug resistance in selected cases. In practice, a broad-spectrum beta-lactam antibiotic (e.g., piperacillin-tazobactam) is the mainstay of empirical therapy; (2) decrease toxin production, typically using a clindamycin combination, mainly in proven or suspected group A streptococcus infections; and (3) achieve the best possible tissue diffusion with regards to impaired regional perfusion, tissue necrosis, and pharmacokinetic and pharmacodynamic alterations. The best duration of antibiotic treatment has not been well established and is generally comprised between 7 and 15 days. This article reviews the currently available knowledge regarding antibiotic use in NSTIs.

31 October 2016 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
CDCecile Ingrid Djuikoue
Cecile Ingrid Djuikoue
PWPaul-Louis Woerther
Paul-Louis Woerther
MTMichel Toukam
Michel Toukam
CBCharles Burdet
Charles Burdet
ERETIENNE RUPPE
ETIENNE RUPPE
JNJeanne Ngogang
Jeanne Ngogang
Introduction: During the last decade, the prevalence of the intestinal carriage of extended spectrum beta-lactamases – producing Escherichia coli (ESBL-E. coli) has continued to increase worldwide in the community, especially in developing countries. Hence, we undertook a study to determine the ESBL-E. coli fecal carriage rate and the associated risk factors in Cameroonian women. Methodology: A total of 86 women suspected of community-acquired urinary tract infections (UTI) were included in 10 health structures from May 2011 to April 2012. After filling a questionnaire, they provided a stool sample that was plated on selective media for ESBL producing bacteria. The identification of strains was obtained with mass spectrometry and the antibiotic susceptibility by disk diffusion in agar media. The ESBL type was determined by PCR. The relative abundance of ESBL-E. coli was measured for positive samples. Eventually, the presence of antibiotics in stool was assessed. Results: The carriage rate of ESBL-E. coli was 57/86 (66.3%). Phenotypic and molecular characterization showed that all ESBL-E. coli strains contained group 1 CTX-M enzymes. Multivariate analysis showed that ESBL-E. coli fecal carriage was associated with the presence of antibiotics in stools (p < 0.05). Although not significant, mean ESBL relative abundance tended to be higher in patients with antibiotic exposure. Conclusions: Our results show that the carriage of ESBL-E. coli fecal carriage in women with UTI suspicion from the Cameroonian community is extremely high and associated with recent antibiotic intake.

16 December 2019 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MEMehdi Ellouze
Mehdi Ellouze
LVLola Vigouroux
Lola Vigouroux
CTColas Tcherakian
Colas Tcherakian
PWPaul‐Louis Woerther
Paul‐Louis Woerther
AGAurélie Guguin
Aurélie Guguin
VGVéronique Godot
Véronique Godot

1 October 2017 in Anaerobe
Verified
Journal Article
Closed access
PWPaul-Louis Woerther
Paul-Louis Woerther
SASami Antoun
Sami Antoun
ECElisabeth Chachaty
Elisabeth Chachaty
MMMansouria Merad
Mansouria Merad